Table 5 Isokinetic Muscle Endurance Indices for the CoQ10 and Placebo (CON) groups.
Variable | Time | CoQ10 | Placebo | Significance | |
|---|---|---|---|---|---|
Peak Torque EXT (N/m) | Baseline | 132 ± 42 | 110 ± 38 | Group | 0.181 |
|  | Day 0 | 127 ± 37 | 110 ± 34 | Time | 0.265 |
|  | Day 14 | 132 ± 34 | 107 ± 35 | G × T | 0.495 |
Peak Torque FLX (N/m) | Baseline | 72 ± 28 | 65 ± 26 | Group | 0.218 |
|  | Day 0 | 75 ± 28 | 66 ± 28 | Time | 0.534 |
|  | Day 14 | 73 ± 24 | 65 ± 28 | G × T | 0.488 |
Total Work EXT (N/m) | Baseline | 4047 ± 1218 | 3391 ± 992 | Group | 0.826 |
|  | Day 0 | 3955 ± 1114 | 3352 ± 936 | Time | 0.308 |
|  | Day 14 | 4073 ± 1116 | 3242 ± 921 | G × T | 0.442 |
Total Work FLX (N/m) | Baseline | 2213 ± 847 | 1962 ± 891 | Group | 0.127 |
|  | Day 0 | 2203 ± 877 | 1996 ± 963 | Time | 0.493 |
|  | Day 14 | 2230 ± 822 | 1866 ± 839 | G × T | 0.591 |
Work Fatigue EXT (%) | Baseline | 48 ± 15 | 41 ± 17 | Group | 0.112 |
|  | Day 0 | 46 ± 14 | 37 ± 19 | Time | 0.160 |
|  | Day 14 | 48 ± 11 | 36 ± 20 | G × T | 0.309 |
Work Fatigue FLX (%) | Baseline | 46 ± 20 | 43 ± 29 | Group | 0.132 |
|  | Day 0 | 51 ± 14 | 35 ± 30 | Time | 0.534 |
|  | Day 14 | 51 ± 16 | 44 ± 14 | G × T | 0.192 |
AVG Power EXT (Watts) | Baseline | 117 ± 36 | 95 ± 30 | Group | 0.476 |
|  | Day 0 | 115 ± 34 | 95 ± 27 | Time | 0.315 |
|  | Day 14 | 117 ± 33 | 95 ± 30 | G × T | 0.351 |
AVG Power FLX (Watts) | Baseline | 61 ± 25 | 52 ± 25 | Group | 0.106 |
|  | Day 0 | 62 ± 26 | 54 ± 27 | Time | 0.334 |
|  | Day 14 | 62 ± 24 | 52 ± 26 | G × T | 0.402 |